Below are the financial statements of Fisher & Paykel Healthcare, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of NZD | 2025 | 2024 |
|---|---|---|
| Operating revenue | 2,021a | 1,742.8a |
| Cost of sales | -750.1a | -698.4a |
| Gross profit | 1,270.9a | 1,044.4a |
| Selling, general and administrative expenses | -534.4a | -492.8a |
| Research and development expenses | -226.9a | -198.2a |
| Total operating expenses | -761.3a | -691a |
| Operating profit | 509.6a | 353.4a |
| Revaluation of land | 0a | -98.1a |
| Profit before financing and tax | 509.6a | 255.3a |
| Financing income | 4.3a | 3.3a |
| Financing expense | -11.1a | -18.2a |
| Exchange gain/(loss) on translation of foreign currency assets and liabilities | 0.5a | -4.7a |
| Net financing expense | -6.3a | -19.6a |
| Profit before tax | 503.3a | 235.7a |
| Tax expense | -126.1a | -103.1a |
| Profit after tax | 377.2a | 132.6a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.